Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,173.91
(
0.12%
)
US TECH 100
26,487.20
(
-0.31%
)
Dow Jones
49,310.32
(
0.00%
)
Brent Oil
104.31
(
2.15%
)
Bitcoin
76,780.01
(
-0.76%
)
News Focus
News Focus
Post# of 517623
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

LakeshoreLeo1953

Send PM Follow Ignore
Followers 36
Posts 11712
Boards Moderated 0
Alias Born 02/26/2016

LakeshoreLeo1953

Re: ExtremelyBullishZig post# 439322

Monday, 11/20/2023 8:31:49 AM

Monday, November 20, 2023 8:31:49 AM

Post# of 517623

These meetings discussed the debilitating pathology of Alzheimer’s disease
and Anavex’s blarcamesine (ANAVEX®2-73) Alzheimer’s disease clinical program results, i
ncluding data obtained in the ANAVEX®2-73-AD-004 study.



It is a PR and I am notoriously skeptical, but I won't split hairs about a sit down with REAL people not a plan to pursue contact.
I am certainly not prepared to say that those discussions included Anavex
lying about the data.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News